NCT04195191

Intervention to Improve the Adherence in Community Pharmacies

Effectiveness of an Intervention to Improve the Adherence to Treatment of New Medicines From the Community Pharmacy

• Status: Unknown
• Phase: N/A
• Study type: Interventional
• Enrollment: 500 (estimated)
• Sponsor: Andalusian School of Public Health · Other Government
• Sex: All
• Age: 18 Years
• Healthy volunteers: Accepted

Summary

The ANM is the first initiative that puts advanced pharmaceutical care into practice in Andalusia (Spain). The aim of this is study is to evaluate the effectiveness of the intervention Assistance to New Medicines (ANM) in the improvement of adherence to treatment in community pharmacies.

Detailed description

Design: parallel cluster pragmatic randomized controlled trial. The study includes patients users of a community pharmacies, who meet the following inclusion criteria: patient who starts treatment of any of the following pathologies: Chronic Obstructive Pulmonary Disease (COPD), Arterial Hypertension or Diabetes Mellitus in Andalusia (Spain). In order to avoid possible contamination between patients assigned to the control and intervention group, randomization will be carried out at the pharmacy level; preventing the pharmacist from applying part of the intervention to the control group. Interventions: patients randomized: (i) current practice; or (ii) ANM intervention thru a pharmacist delivered support for a newly prescribed medicine.

Conditions

• Chronic Obstructive Pulmonary Disease (COPD
• Arterial Hypertension
• Diabetes Mellitus

Interventions

Type	Name	Description
OTHER	ANM	communication intervention
OTHER	Placebo	regular assistance in community pharmacies

Timeline

• Start date: 2019-01-18
• Primary completion: 2020-03-02
• Completion: 2020-07-01
• First posted: 2019-12-11
• Last updated: 2020-02-05

Locations

1 site across 1 country: Spain